K. Radig

发表

p53 gene mutations in soft-tissue sarcomas-correlations with p53 immunohistochemistry and DNA ploidy

R. Schneider-Stock, K. Radig, Y. Oda, 2005, Journal of Cancer Research and Clinical Oncology.

No correlation of c-myc overexpression and p53 mutations in liposarcomas

R. Schneider-Stock, K. Radig, J. Ryś, 1998, Virchows Archiv.

Telomeric lengths and telomerase activity in liposarcomas

R. Schneider-Stock, K. Radig, J. Ryś, 1999, Molecular carcinogenesis.

On telomere shortening in soft-tissue tumors

R. Schneider-Stock, K. Radig, Y. Oda, 1998, Journal of Cancer Research and Clinical Oncology.

Expression of MDR1/p-glycoprotein and multidrug resistance-associated protein in childhood solid tumours

K. Radig, Y. Oda, A. Roessner, 2005, Virchows Archiv.

Clinicopathologic implications of MDM2, p53 and K-ras gene alterations in osteosarcomas: MDM2 amplification and p53 mutations found in progressive tumors.

R. Schneider-Stock, K. Radig, A. Roessner, 1998, Pathology, Research and Practice.

p53 and ras mutations in Ewing's sarcoma.

R. Schneider-Stock, K. Radig, Y. Oda, 1998, Pathology, research and practice.

MDM2 amplification and loss of heterozygosity at Rb and p53 genes: no simultaneous alterations in the oncogenesis of liposarcomas

R. Schneider-Stock, K. Radig, J. Ryś, 1998, Journal of Cancer Research and Clinical Oncology.

Loss of heterozygosity on chromosome 9q21 (p16 gene) uncommon in soft‐tissue sarcomas

R. Schneider-Stock, K. Radig, A. Roessner, 1997, Molecular carcinogenesis.

Aggressive osteoblastoma with focal malignant transformation and development of pulmonary metastases. A case report with a review of literature.

R. Schneider-Stock, K. Radig, E. Kunze, 1996, General & diagnostic pathology.

The urokinase plasminogen activator (u-PA) and its inhibitor (PAI-1) in embryo-fetal bone formation in the human: an immunohistochemical study

K. Radig, A. Roessner, I. Röse, 1995, Anatomy and Embryology.

Desmoplastic small round cell tumor.

K. Radig, I. Leuschner, D. Harms, 1996, Seminars in diagnostic pathology.

Immunohistochemical analysis of nm23 protein expression in malignant bone tumors

K. Radig, Y. Oda, A. Roessner, 1995, Journal of Cancer Research and Clinical Oncology.

p53 gene mutations in osteosarcomas of low-grade malignancy.

R. Schneider-Stock, K. Radig, A. Roessner, 1998, Human pathology.

Genetic instability in osteoblastic tumors of the skeletal system.

R. Schneider-Stock, K. Radig, A. Roessner, 1998, Pathology, research and practice.

Current aspects of the pathology of osteosarcoma.

R. Schneider-Stock, K. Radig, A. Roessner, 1995, Anticancer research.

Protease expression in dedifferentiated parosteal osteosarcoma.

K. Radig, A. Roessner, C. Haeckel, 1999, Archives of pathology & laboratory medicine.

Mutation spectrum of p53 gene in highly malignant human osteosarcomas.

R. Schneider-Stock, K. Radig, Y. Oda, 1996, General & diagnostic pathology.

Alveolar soft part sarcoma of the uterine corpus. Report of two cases and review of the literature.

K. Radig, A. Roessner, P. Buhtz, 1998, Pathology, research and practice.

Expression of P-glycoprotein in high grade osteosarcomas with special emphasis on chondroblastic subtype.

K. Radig, Y. Oda, A. Roessner, 1997, General & diagnostic pathology.

Gene alterations at the CDKN2A (p16/MTS1) locus in soft tissue tumors.

R. Schneider-Stock, K. Radig, A. Roessner, 1998, International journal of oncology.

Improved detection of P53 mutations in soft tissue tumors using new gel composition for automated nonradioactive analysis of single‐strand conformation polymorphism

R. Schneider-Stock, K. Radig, A. Roessner, 1997, Electrophoresis.

Expression of plasminogen activators and plasminogen activator inhibitor 1 in dedifferentiated chondrosarcoma

B. Czerniak, K. Radig, A. Roessner, 1997, Cancer.

[Genetic instability in osteoblastic tumors of the skeletal system].

R. Schneider-Stock, K. Radig, A. Roessner, 1998, Verhandlungen der Deutschen Gesellschaft fur Pathologie.

Expression of growth factors and their receptors in human osteosarcomas. Immunohistochemical detection of epidermal growth factor, platelet-derived growth factor and their receptors: its correlation with proliferating activities and p53 expression.

K. Radig, W. Neumann, H. Walter, 1995, General & diagnostic pathology.